You have 9 free searches left this month | for more free features.

City

Baltimore (1)

Boston (1)

Durham (1)

Condition

Migraine (1)

Pain, Chronic (1)

Schwannomas (1)

Schwannomatosis (1)

Trigeminal Neuropathy (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Amgen (1)

Massachusetts General Hospital (1)

University of Maryland, Baltimore (1)

Collaborator

Amgen (1)

Recordati Rare Diseases (1)

United States Department of Defense (1)

Intervention

erenumab-aooe (3)

erenumab-aooe matching placebo (1)

placebo (1)

siltuximab (1)

siltuximab matching placebo (1)

Study Documents

Intervention Type

drug (3)

other (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Observational (1)

erenumab-aooe

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Aimovig Pregnancy Exposure Registry

Recruiting

Migraine

erenumab-aooe

Durham, North Carolina

IQVIA Virtual Site

Nov 21, 2023

Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

Not yet recruiting

Schwannomatosis
+2 more

Siltuximab
+3 more

Boston, Massachusetts

Massachusetts General Hospital Cancer Center

Jan 5, 2023

Trigeminal Neuropathy Trial in Baltimore (Erenumab-Aooe, Placebo)

Terminated

Trigeminal Neuropathy

Erenumab-Aooe
Placebo

Baltimore, Maryland

University of Maryland, School of Dentistry, Brotman Facial Pain

Dec 11, 2022